ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Seeks $5.799 Billion In FY08 Bypass Budget

November 17, 2006

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

RFP: Intellectual Property.

March 31, 2000

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984